{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:24:07Z","timestamp":1782260647998,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["20161413"],"award-info":[{"award-number":["20161413"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771648"],"award-info":[{"award-number":["81771648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1001403"],"award-info":[{"award-number":["2017YFC1001403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0802604"],"award-info":[{"award-number":["2019YFA0802604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17DZ2271100"],"award-info":[{"award-number":["17DZ2271100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["2017BR015"],"award-info":[{"award-number":["2017BR015"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.metabol.2021.154749","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T16:30:08Z","timestamp":1615566608000},"page":"154749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Addressing the role of 11\u03b2-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model"],"prefix":"10.1016","volume":"119","author":[{"given":"Xinyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanggang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jufang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154749_bb0005","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2021.154749_bb0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2021.154749_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2021.154749_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2021.154749_bb0025","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.fertnstert.2011.01.133","article-title":"Diabetes risk score in the diagnostic categories of polycystic ovary syndrome","volume":"95","author":"Moran","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2021.154749_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.metabol.2019.02.002","article-title":"Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome","volume":"94","author":"Meijiao","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154749_bb0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tem.2017.02.005","article-title":"Glucocorticoids and reproduction: traffic control on the road to reproduction","volume":"28","author":"Whirledge","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154749_bb0040","first-page":"154047","article-title":"Perinatal programming of metabolic diseases: the role of glucocorticoids","volume":"104","author":"J\u00falia","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2021.154749_bb0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/rep.0.1260425","article-title":"Glucocorticoid metabolism and reproduction: a tale of two enzymes","volume":"126","author":"Michael","year":"2003","journal-title":"Reproduction."},{"key":"10.1016\/j.metabol.2021.154749_bb0050","doi-asserted-by":"crossref","first-page":"154246","DOI":"10.1016\/j.metabol.2020.154246","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitor use in human disease - a systematic review and narrative synthesis","volume":"108","author":"Gregory","year":"2020","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154749_bb0055","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/hep.29734","article-title":"11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis","volume":"67","author":"Zou","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154749_bb0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2018.10.002","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy","volume":"125","author":"Huang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154749_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/path.4806","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation","volume":"240","author":"Hardy","year":"2016","journal-title":"J Pathol"},{"issue":"106","key":"10.1016\/j.metabol.2021.154749_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/clinem\/dgaa766","article-title":"11\u03b2HSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension","volume":"1","author":"Hardy","year":"2021","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.metabol.2021.154749_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2011.01375.x","article-title":"Effects of an 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome","volume":"13","author":"Feig","year":"2011","journal-title":"Diabetes Obesity Metab"},{"key":"10.1016\/j.metabol.2021.154749_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2010.01305.x","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus","volume":"13","author":"Hollis","year":"2011","journal-title":"Diabetes Obesity Metab"},{"key":"10.1016\/j.metabol.2021.154749_bb0085","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1210\/jc.2015-3899","article-title":"Local regeneration of cortisol by 11\u03b2-HSD1 contributes to insulin resistance of the granulosa cells in PCOS","volume":"101","author":"Zhu","year":"2016","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.metabol.2021.154749_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/EJE-13-1030","article-title":"Tissue-specific dysregulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in overweight\/obese women with polycystic ovary syndrome compared with weight-matched controls","volume":"171","author":"Gambineri","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2021.154749_bb0095","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0033-1345186","article-title":"The expression of 11\u03b2-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects","volume":"45","author":"Li","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2021.154749_bb0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.metabol.2021.154749_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mce.2014.08.013","article-title":"Possible involvement of glucocorticoids in 5\u03b1-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue","volume":"399","author":"Nikoli\u0107","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2021.154749_bb0110","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db13-1514","article-title":"Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell","volume":"63","author":"Wu","year":"2014","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154749_bb0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.metabol.2021.154749_bb0120","first-page":"505","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","author":"Liu","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2021.154749_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2018-00075","article-title":"Ovulation: parallels with inflammatory processes","volume":"40","author":"Duffy","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2021.154749_bb0130","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1210\/jc.2013-1385","article-title":"Ovarian 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2HSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens","volume":"98","author":"Michael","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154749_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1210\/en.2002-220652","article-title":"Lysyl oxidase gene expression and enzyme activity in the rat ovary: regulation by follicle-stimulating hormone, androgen, and transforming growth factor-beta superfamily members in vitro","volume":"144","author":"Harlow","year":"2003","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154749_bb0140","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1080\/00016340601033741","article-title":"Collagens in the human ovary and their changes in the perifollicular stroma during ovulation","volume":"85","author":"Lind","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.metabol.2021.154749_bb0145","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1210\/en.2016-1406","article-title":"Inhibition of lysyl oxidase by cortisol regeneration in human amnion: implications for rupture of fetal membranes","volume":"157","author":"Liu","year":"2016","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154749_bb0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.reprotox.2009.10.009","article-title":"The effect of glucocorticoids on ERK-1\/2 phosphorylation during maturation of lamb oocytes and their subsequent fertilization and cleavage ability in vitro","volume":"29","author":"Gonz\u00e1lez","year":"2010","journal-title":"Reproduct Toxicol"},{"key":"10.1016\/j.metabol.2021.154749_bb0155","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/humrep\/dey292","article-title":"Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome","volume":"33","author":"Zhang","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2021.154749_bb0160","doi-asserted-by":"crossref","unstructured":"Papachroni KK, Piperi C, Levidou G, Korkolopoulou P, Pawelczyk L, Diamanti-Kandarakis E, et al. Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue. J CellMol Med 2010;14:2460\u20139.","DOI":"10.1111\/j.1582-4934.2009.00841.x"},{"key":"10.1016\/j.metabol.2021.154749_bb0165","first-page":"8774","article-title":"Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome","volume":"8","author":"Bulut","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.metabol.2021.154749_bb0170","first-page":"35","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"E","year":"2009"},{"key":"10.1016\/j.metabol.2021.154749_bb0175","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.1523236113","article-title":"Brown adipose tissue transplantation ameliorates polycystic ovary syndrome","volume":"113","author":"Yuan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154749_bb0180","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1073\/pnas.1312436111","article-title":"Elevated hepatic 11\u03b2-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia","volume":"111","author":"Ananda","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154749_bb0185","doi-asserted-by":"crossref","first-page":"154241","DOI":"10.1016\/j.metabol.2020.154241","article-title":"Decreased microRNA-125b-5p disrupts follicle steroidogenesis through targeting PAK3\/ERK1\/2 signalling in mouse preantral follicles","volume":"107","author":"Zhang","year":"2020","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154749_bb0190","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154749_bb0195","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/en.2003-0344","article-title":"Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains","volume":"144","author":"Alberts","year":"2003","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154749_bb0205","doi-asserted-by":"crossref","unstructured":"NK S, A M-A, LC M, KA W, endocrinology RRJTJoc, metabolism. Molecular mechanisms of insulin resistance in polycystic ovary syndrome: unraveling the conundrum in skeletal muscle? 2019;104:5372\u201381.","DOI":"10.1210\/jc.2019-00167"},{"key":"10.1016\/j.metabol.2021.154749_bb0210","first-page":"1","article-title":"The upregulation of 11\u03b2-HSD1 in ovarian granulosa cells by cortisol and interleukin-1\u03b2 in polycystic ovary syndrome","author":"Hasiximuke","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.metabol.2021.154749_bb0215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2021.154749_bb0220","first-page":"1","article-title":"Polycystic ovary syndrome","volume":"2","author":"Ricardo","year":"2016","journal-title":"Nat Rev Disease Primers"},{"key":"10.1016\/j.metabol.2021.154749_bb0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12861-015-0054-0","article-title":"Development of the follicular basement membrane during human gametogenesis and early folliculogenesis","volume":"15","author":"Heeren","year":"2015","journal-title":"BMC Dev Biol."},{"key":"10.1016\/j.metabol.2021.154749_bb0230","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI64162","article-title":"11\u03b2-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects","volume":"123","author":"Tiganescu","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154749_bb0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/me.2010-0318","article-title":"CCAAT\/enhancer-binding proteins (C\/EBP)-\u03b1 and -\u03b2 are essential for ovulation, luteinization, and the expression of key target genes","volume":"25","author":"Fan","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2021.154749_bb0240","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.1171396","article-title":"MAPK3\/1 (ERK1\/2) in ovarian granulosa cells are essential for female fertility","volume":"324","author":"Fan","year":"2009","journal-title":"Science."},{"key":"10.1016\/j.metabol.2021.154749_bb0245","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncpendmet0787","article-title":"Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome\u2014a reappraisal","volume":"4","author":"Dunaif","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154749_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"}],"updated-by":[{"DOI":"10.1016\/j.metabol.2025.156437","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:16:10Z","timestamp":1766121370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"alternative-id":["S0026049521000494"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154749","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing the role of 11\u03b2-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154749"}}